PAPER Taguchi K, Watanabe Y, Tanaka M

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation.

iScience. 2025 Feb 21;28(2):111935. Epub 2025 Jan 31 PubMed.

PAPER Elbatrawy AA, Ademoye TA, Alnakhala H, Tripathi A, Zhu X, Plascencia-Villa G, Perry G, Dettmer U, Fortin JS

Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates.

ACS Omega. 2025 Feb 25;10(7):6721-6734. Epub 2025 Feb 12 PubMed.

PAPER Szegvari E, Holec SA, Woerman AL

Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research.

J Neurochem. 2025 Mar;169(3):e70021. PubMed.

PAPER Abdi IY, Hashish SA, El-Agnaf OA

Seeding amplification assay: Limitations and insights for enhanced clinical and research applications.

J Parkinsons Dis. 2025 Mar 2;:1877718X251325124. Epub 2025 Mar 2 PubMed.

PAPER Huang YT, Yang TJ, Liu KC, Chen MC, Chan PS, Chen JC

Intranasal α-Synuclein Induces Progressive Behavioral Impairments in Mice.

Behav Brain Res. 2025 Feb 28;:115517. Epub 2025 Feb 28 PubMed.

PAPER Ali TT, Merghani M, Al-Azzani M, Gatzemeier LM, Hoppert M, Kaloyanova D, Outeiro TF, Neumann P, Popova B, Braus GH

Rationally designed peptides inhibit the formation of α-synuclein fibrils and oligomers.

Eur J Med Chem. 2025 Feb 26;289:117452. Epub 2025 Feb 26 PubMed.

PAPER Downes MH, Kalagara R, Rossitto CP, Vasan V, Vasa D, Chennareddy S, Lefton DR, Yildiz S, Umphlett M, Brockington C, Kellner CP

Validation of the Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy in Patients Presenting With Intracerebral Hemorrhage.

Neurology. 2025 Apr 8;104(7):e213460. Epub 2025 Mar 3 PubMed.

PAPER Alten B, Gokcal E, Warren A, van Veluw SJ, Kozberg M, Gurol ME, Viswanathan A, Greenberg SM

Cerebrospinal Fluid Beta-Amyloid Concentration and Clinical and Radiographic Manifestations of Cerebral Amyloid Angiopathy.

J Am Heart Assoc. 2025 Mar 4;14(5):e040025. Epub 2025 Mar 3 PubMed.

PAPER Zhang Z, Wang T, Hu Z, Yang LZ, Li H

DEMENTIA: A Hybrid Attention-Based Multimodal and Multi-Task Learning Framework With Expert Knowledge for Alzheimer's Disease Assessment From Speech.

IEEE J Biomed Health Inform. 2024 Dec 18;PP Epub 2024 Dec 18 PubMed.

PAPER McCool S, Smith JC, Sladek A, Fan S, Van Hook MJ

Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease.

PLoS One. 2025;20(3):e0319397. Epub 2025 Mar 3 PubMed.

PAPER Verma R, Sharma P, Sharma V, Singh TG

Modulating lipid droplet dynamics in neurodegeneration: an emerging area of molecular pharmacology.

Mol Biol Rep. 2025 Mar 3;52(1):277. PubMed.

PAPER Aiswarya A, Girish S, Siddhartha V, Sameer Z, Ashwinirani SR

Periodontal Disease as a Potential Risk Factor for Alzheimer's Disease- An Evaluative Study.

Indian J Dent Res. 2025 Mar 3; Epub 2025 Mar 3 PubMed.

PAPER Bahmani Kolour P, Ghazvini H, Naderi M, Ghalehnoei H, Rezaei Talarposhti M

Effects of memantine and donepezil on social memory, anxiety-like behavior and the expression levels of microRNA-124, microRNA-125b, and microRNA-132 in scopolamine-induced memory impairment in rats.

Neurol Res. 2025 Mar 3;:1-12. Epub 2025 Mar 3 PubMed.

PAPER Zegarra-Valdivia JA, Shany-Ur T, Rijpma MG, Callahan P, Poorzand P, Grossman S, McEachen B, Kramer JH, Miller BL, Rankin KP

Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration.

J Alzheimers Dis. 2025 Mar 3;:13872877251317683. Epub 2025 Mar 3 PubMed.

PAPER Jia M, Hu F, Hui Y, Peng J, Wang W, Zhang J

Effects of exercise on older adults with mild cognitive impairment: A systematic review and network meta-analysis.

J Alzheimers Dis. 2025 Mar 3;:13872877251321176. Epub 2025 Mar 3 PubMed.